Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review

Barrett's esophagus is a condition in which the normal squamous lining of the esophagus has been replaced by columnar epithelium containing intestinal metaplasia induced by recurrent mucosal injury related to gastroesophageal reflux disease. Barrett's esophagus is a premalignant condition that can progress through a dysplasia-carcinoma sequence to esophageal adenocarcinoma. Multiple endoscopic ablative techniques have been developed with the goal of eradicating Barrett's esophagus and preventing neoplastic progression to esophageal adenocarcinoma. For patients with high-grade dysplasia or intramucosal neoplasia, radiofrequency ablation with or without endoscopic resection for visible lesions is currently the most effective and safe treatment available. Recent data demonstrate that, in patients with Barrett's esophagus and low-grade dysplasia confirmed by a second pathologist, ablative therapy results in a statistically significant reduction in progression to high-grade dysplasia and esophageal adenocarcinoma. Treatment of dysplastic Barrett's esophagus with radiofrequency ablation results in complete eradication of both dysplasia and of intestinal metaplasia in a high proportion of patients with a low incidence of adverse events. A high proportion of treated patients maintain the neosquamous epithelium after successful treatment without recurrence of intestinal metaplasia. Following successful endoscopic treatment, endoscopic surveillance should be continued to detect any recurrent intestinal metaplasia and/or dysplasia. This paper reviews all relevant publications on the endoscopic management of Barrett's esophagus using radiofrequency ablation.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  N. Nishioka,et al.  The cost effectiveness of radiofrequency ablation for Barrett's esophagus. , 2012, Gastroenterology.

[3]  S. Paterson-Brown,et al.  Surgical and endoscopic management of high grade dysplasia and early oesophageal adenocarcinoma. , 2016, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[4]  G. Ginsberg,et al.  Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. , 2015, Gastroenterology.

[5]  Carissa A. Sanchez,et al.  Biologic Properties of Columnar Epithelium Underneath Reepithelialized Squamous Mucosa in Barrett's Esophagus , 2005, The American journal of surgical pathology.

[6]  G. Meijer,et al.  Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated , 2010, The American Journal of Gastroenterology.

[7]  N. Shaheen,et al.  Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  Ananya Das,et al.  Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia , 2009, The American Journal of Gastroenterology.

[9]  N. Soehendra,et al.  Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial , 2011, Gut.

[10]  J. Pandolfino,et al.  Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. , 2012, Gastroenterology.

[11]  N. Shaheen,et al.  Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location. , 2015, Gastrointestinal endoscopy.

[12]  Nan Li,et al.  Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  J. Tijssen,et al.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. , 2014, JAMA.

[14]  N. Thosani,et al.  Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: efficacy, safety and cost-comparison. , 2013, World Journal of Gastroenterology.

[15]  Paul Fockens,et al.  Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[17]  P. Mavrelis,et al.  Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry , 2010, Endoscopy.

[18]  G. Hanna,et al.  Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events. , 2014, Gastrointestinal endoscopy.

[19]  J. Peters,et al.  Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. , 2010, Journal of the American College of Surgeons.

[20]  Jan G P Tijssen,et al.  Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel , 2014, Gut.

[21]  W. Melvin,et al.  Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center , 2014, Surgical Endoscopy.

[22]  Kenneth K Wang,et al.  Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  K. Binmoeller,et al.  Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett’s esophagus , 2013, Endoscopy.

[24]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[25]  R C Heading,et al.  Barrett's oesophagus. , 1987, British medical journal.

[26]  H. El‐Serag,et al.  Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. , 2008, Gastrointestinal endoscopy.

[27]  N. Shaheen,et al.  Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. , 2012, Gastrointestinal endoscopy.

[28]  Jashanpreet Singh,et al.  The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis , 2011, Gut.

[29]  Hugh Barr,et al.  Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. , 2013, Gastroenterology.

[30]  D. Fleischer,et al.  A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). , 2008, Endoscopy.

[31]  Kenneth J. Chang,et al.  Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.

[32]  B. Overholt,et al.  Durability and predictors of successful radiofrequency ablation for Barrett's esophagus. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  Nicholas J Shaheen,et al.  ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.

[34]  P. Fockens,et al.  Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.

[35]  J. Peters,et al.  Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia. , 2014, Seminars in thoracic and cardiovascular surgery.

[36]  Hiroshi Mashimo,et al.  Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. , 2011, Gastroenterology.

[37]  Amitabh Srivastava,et al.  Radiofrequency ablation for Barrett’s-associated intramucosal carcinoma: a multi-center follow-up study , 2014, Surgical Endoscopy.

[38]  H. Wolfsen,et al.  Adverse Events After Radiofrequency Ablation in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  H. Pohl,et al.  Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study. , 2013, Gastrointestinal endoscopy.

[40]  Kenneth K Wang,et al.  Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. , 2012, Gastroenterology.

[41]  L. Gossner,et al.  Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's oesophagus , 2007, Scandinavian journal of gastroenterology.

[42]  G. Ginsberg,et al.  Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. , 2013, Gastroenterology.

[43]  P. Fockens,et al.  Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.

[44]  Eric J Feuer,et al.  Trends in esophageal adenocarcinoma incidence and mortality , 2013, Cancer.

[45]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[46]  A. Meining,et al.  Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett’s esophagus with early neoplasia: a prospective multicenter study , 2013, Endoscopy.